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   ABSTRACT 
OBJECTIVES: To investigate whether prolongation of the heart rate-corrected QT 
interval (QTc) is an independent risk factor for predicting future acute coronary 
syndrome (ACS) occurrence or mortality in patients with at least one cardiac risk factor 
presenting with chest pain to the Emergency Department (ED). 
BACKGROUND: QTc prolongation is associated with ventricular arrhythmias and 
increased mortality in patients with ACS or known coronary artery disease (CAD). In 
contrast, population-based studies have shown no consistent association between QTc 
prolongation and ACS or mortality in a population with no known CAD. The prognostic 
implications of QTc prolongation on clinical outcomes in patients who present to the ED 
with chest pain is not known. 
METHODS: Single center, retrospective study in patients presenting with chest pain to 
the Einstein Medical Center Philadelphia ED between 2011 and 2012. Proportional 
hazards models were used to calculate hazard ratios for occurrence of ACS or death 
within 1 year. Kaplan Meier Curves were used to determine time to event for QTc low  
(<460 ms) versus  QTc high (>460 ms) groups. 
RESULTS:  Five hundred ninety five patients met criteria. Older age, hypertension, 
diabetes mellitus and hyperlipidemia were more common in the QTc high group.  
Patients in the QTc high group were more likely to experience subsequent ACS or 
death (HR 8.12 95% CI 4.00-16.72), even after adjusting for traditional cardiac risk 
factors (HR 7.68 95% CI 3.57-16.61). 
Conclusion: QTc prolongation at ED presentation with chest pain and at least one 
cardiac risk factor predicts subsequent ACS and death. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
  The International Long QT Syndrome Registry found that the risk of 
developing malignant arrhythmias in patients with QT prolongation is exponentially 
related to the length of the QT interval.[1] However, the role of the heart rate-corrected 
QT interval (QTc) for prognostication in a population with no known coronary artery 
disease (CAD), versus those with CAD, is not known.[2,3,4,5,6,7] The availability and 
widespread use of digitized electrocardiographic recordings for patients presenting with 
chest pain to the ED provides readily accessible data in determining the QTc interval.  
                       Retrospective studies found that QTc prolongation is associated with a 
higher risk of morbidity and mortality in patients with known CAD.[1] QTc prolongation 
has been associated with ventricular arrhythmias and increased mortality in ACS 
patients.[11,12] In contrast, population-based studies have shown no consistent 
association between QTc prolongation and occurrence of ACS or mortality in a healthy 
asymptomatic population.[2,3,4,5,6,7,13] Further, the effect of QTc prolongation on 
clinical outcomes of patients who present to the ED with chest pain is not known. The 
objective of this study was to investigate whether QTc prolongation is an independent 
risk factor for predicting ACS occurrence or mortality in patients, with at least one 
cardiac risk factor, presenting to the ED with chest pain. . 
 
  
 
Methods 
This was a retrospective review of medical records including all patients 18 years or 
older presenting to the Einstein Medical Center Philadelphia ED between June 2011 
and June 2012 with chest pain, who had known cardiac risk factors, but no prior CAD 
history. Cardiac risk factors included hypertension, dyslipidemia, family history of CAD, 
diabetes mellitus, smoking and obesity ( body mass index [BMI>26]). This study was 
approved by the Einstein Medical Center Institutional Review Board (IRB). 
Patients taking medications that prolong the QT interval (e.g. methadone, specific 
antiarrhythmics, antihistamines, antibiotics and psychotropics), had electrolyte 
abnormalities (hypokalemia, hypocalcemia), had central nervous system injury, known 
CAD and those with baseline atrial fibrillation or bundle branch block were excluded. 
Demographic data including age, gender, BMI, hypertension, hyperlipidemia, diabetes 
mellitus, family history of premature CAD and smoking status were collected from 
patient charts (Table 1). QTc intervals were collected from the index electrocardiogram 
and were classified as high or low based on  a cut point set of 460 msec (cut off used in 
majority of prior studies) [9,11,12]. The QT interval was corrected for heart rate in 
surface ECG using Bazett’s formula. Electronic medical records of Einstein Medical 
Center Philadelphia were used to access subsequent ACS diagnoses. Patients were 
followed for a mean of 1 year for subsequent ACS diagnosis or death (Social Security 
Death Index), whichever happened first.  Social security death index was used to 
assess occurrence of death within 1 year after presentation to the ED.  
Data analysis:  Patient groups were compared with and without QT prolongation with 
regards to each of the demographic variables using Student t-tests for quantitative 
variables and chi squared tests for categorical variables. Hazards ratio were calculated 
for death or ACS within one year. Proportional hazards model/cox model was 
constructed to adjust for the effect of demographics on mortality and ACS within one 
year, and to calculate the adjusted hazards ratios.  Kaplan Meier curve was used to 
estimate time to event for the QTc low and high groups. Log rank p values were used to 
compare curves.  JMP 10 (SAS, Cary, NC) was used for all statistics. A p value of 0.05 
or less was considered statistically significant.  
 
 
 
 
 
 
 
 
 
 
Results 
Of 700 charts reviewed, 105 charts were excluded: fifty eight due to absence of 
any cardiac risk factor, 20 due to absence of a baseline ECG at the ED visit, 12 had 
atrial fibrillation or bundle branch block, and 13 had electrolyte abnormalities or use of 
drugs known to prolong QTc. Mean follow up was 1 year from index ED visit. 
Demographic variables were compared between groups with and without QT 
prolongation (Table IA). Fifty nine of 595 (10%) patients studied experienced an ACS 
event during the index hospitalization and were not included in outcome measures. 
Patients with QTc > 460 had a higher incidence of older age (>60 years old), 
hypertension, diabetes mellitus and hyperlipidemia. Multivariate analysis for the 
composite of ACS and mortality was performed to account for these significant 
demographic differences (Table IB). Multivariate analysis demonstrated that a 
prolonged QTc was associated with a marked increase in risk of having ACS or death 
within 1 year after ED presentation.  As shown in Figure. 1, the Kaplan Meier survival 
plot shows that ACS and mortality occurrence appears to increase at 4 months after 
index presentation with chest pain in the ED. 
 
    
 
  
 
 
 Discussion 
 
The major finding of this study was that a prolonged QTc interval was associated with a 
more than seven-fold increased risk of ACS or death within 1 year of ED presentation 
for chest pain in patients with at least one cardiac risk factor. This was independent of 
other cardiac risk factors.  
 
Epidemiological studies evaluating total and cardiovascular mortality associated with 
QTc prolongation have yielded conflicting results. The Framingham study failed to show 
an association of baseline QTc prolongation with total mortality, sudden death, or 
coronary mortality in a healthy population.[8] In contrast, the Cardiovascular Health 
Study, showed an association between a QTc  >450 ms and total mortality in a healthy 
population. In the Strong Heart Study, a QTc >460 ms was associated with a two-fold 
increased risk of cardiac and total mortality in a healthy population.[9] In the Rotterdam 
Study, QTc prolongation >440 ms was associated with an increased risk of total and 
cardiovascular mortality, this time with an elderly population.[2] A recent study of Beinart 
et al, found that QTc of >460  or each 10 ms increase in the QTc with patients not 
known to have CAD was associated with increased risk for future rate of strokes, 
cardiovascular events and heart failure readmissions.[12] In studies by Gadelata et al 
and Jiménez-Candil et al, prolongation of QTc interval (>458 msec) in patients with ACS 
on admission ECG was an independent predictor of cardiovascular risk, defined as 
recurrence of ACS within 30 days and at 1 year of follow up.[10, 11] In their studies they 
found a positive correlation between prolonged QTc intervals and cTnT levels. To date, 
no study has examined the prognostic value of the QTc interval in patients presenting to 
the ED with chest pain. Thus, the present study extends the findings summarized 
above, in that patients presenting with chest pain to the ED with at least one cardiac risk 
factor are at increased risk for ACS events and all cause death within one year if their 
QTc is greater than 460 ms.  
 
This is the first study to address a population of patients presenting to the ED 
symptomatic of chest pain and having at least one cardiac risk factor, but with no known 
CAD or past ACS. Factors that may affect QTc prolongation such as drugs, and 
electrolyte abnormalities which were not accounted for in most prior studies were 
excluded in the present study. Also important to note, is the interesting finding that BMI 
defined in our study as BMI>26  was also an independent risk factor for ACS and all 
cause mortality within 1 year for patients presenting with chest pain and at least one 
cardiac risk factor. Further studies are needed to explore this finding. 
 
This study was limited to a single center and was retrospective. We could not control for 
patients who may have gone to other medical centers for occurrence of subsequent 
ACS within 1 year of follow up. Also QTc was not manually calculated but rather was 
obtained from the computer reported ECG on index ED visit. However, this does reflect 
real world care and offers an easy quick look predictor of future ACS and death risk for 
patients presenting to the ED with chest pain.  
 
In conclusion, QTc prolongation at ED presentation in patients with chest pain with at 
least one cardiac risk factor is an independent risk factor for occurrence of ACS or all-
cause mortality within 1 year. Whether this finding can be a potential add on feature to 
risk scores, such as TIMI GRACE or PURSUIT will require prospective studies to 
confirm and compare the predictive value of QTc interval prolongation in patients 
presenting to the ED with chest pain.[13, 14, 15] 
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Figure  Legends 
 
Figure 1:  Kaplan-Meier log survival plot of heart rate corrected QT (QTc) interval 
prolongation and composite outcome of ACS and all cause mortality within 1 year , 
p<.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 1 
 
 QT≤460 
 QT>460 
 
 
•  
 
 
 
  
Table 1a. Baseline characteristics of the study population stratified by the QTc 
prolongation at baseline  
 QTc≤460 
msec  
QTc>460 
msec  
p  
n  445  64   
Male Gender %  49  40.6  0.21  
Age>60 %  28.5  46.9  0.003  
Hypertension %  59.3  81.2  0.0007  
Diabetes 
Mellitus %  
34.4  46.9  0.05  
Hyperlipidemia 
%  
30.2  45.3  0.015  
Family History 
of CAD % 
8.3  9.4  0.77  
Overweight  
BMI >26 %  
68.8  67.2  0.78  
Smoking %  60.1  57.8  0.72  
 
 
   
*Values are percentages as they are dichotomous variables. QTc = heart rate corrected 
QT interval 
  
Table 1b. Survival Analysis (ACS or mortality within one year), Hazard Ratios with 95% 
confidence intervals 
 Univariate analysis  Multivariate 
analysis  
Age>60  2.14 (1.10-4.15)  1.03 (0.47-2.21)  
Hypertension  2.01 (1.01-4.27)  1.48 (0.65-3.70)  
Diabetes Mellitus  2.22 (1.14-4.30)  1.35 (0.63-2.90)  
Hyperlipidemia 3.12 (1.61-6.13)  2.26 (1.08-4.88)  
Family History of 
CAD 
1.58 (0.46-4.06)  1.38 (0.40-3.61)  
BMI>26  2.03 (0.99-4.58)  2.55 (1.08-7.05)  
QTc>460  8.12 (4.00-16.72)  7.68 (3.57-16.61)†  
†Adjusted for age>60, presence of hypertension, diabetes mellitus, hyperlipidemia 
family history of CAD, BMI>26 
 
 
 
 
 
